Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort

Abstract

Systemic Lupus International Collaborating Clinics (SLICC) comprises 27 centres from 11 countries. An inception cohort of 918 SLE patients has been assembled according to a standardized protocol between 2000 and 2006. Clinical features, classic coronary artery disease (CAD) risk factors, as well as other potential risk factors were collected. Of the 918 patients 89% were females, and of multi racial origin. Less than half the patients were living in a permanent relationship, 58% had post secondary education and 51% were employed. Eight percent had family history of SLE. At enrolment, with at mean age of diagnosis of 34.5 years, a significant number of patients already had CAD risk factors, such as hypertension (33%) and hypercholesterolemia (36%). Only 15% of the patients were postmenopausal, 16% were current smokers and 3.6% had diabetes at entry to the SLICC-RAS (Registry for Atherosclerosis). A number of patients in this multi-racial, multi-ethnic inception cohort of lupus patients have classic CAD risk factors within a mean of 5.4 months from diagnosis. This cohort will be increased to 1500 patients to be followed yearly for 10 years. This will provide a unique opportunity to evaluate risk factors for accelerated atherosclerosis in SLE. Lupus (2007) 16, 731—735.

Keywords

lupus inception observation cohort study coronary artery risk factors

Get full access to this article

View all access options for this article.

References

Nikpour M. , Urowitz MB , Gladman DD Premature atherosclerosis in systemic lupus erythematosus. Rheum Dis Clin North Am 2005; 31: 329—354.

Urowitz MB , Ibañez D. , Gladman DD Atherosclerotic vascular events (AVE) in a single large lupus cohort: prevalence and risk factors. J Rheumatol 2007; 34: 70—75.

Manzi S. , Meilahn EN , Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997; 145: 408—415.

Petri M. , Perez-Gutthan S. , Spence D. , Hochberg MC Risk factors for coronary artery disease in patients with systemic lupus erythematosus . Am J Med 1992; 93: 513—519.

Gladman DD , Urowitz MB Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14(Suppl 13): 223—226.

Manzi S. , Selzer F. , Sutton-Tyrrel K. et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51—60.

Esdaile JM , Abrahamowicz M. , du Berger R. et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001; 44: 2331—2337.

Isenberg DA , Gladman D. The systemic Lupus International Collaborating Clinics Group — origins and outcomes. Lupus 2001; 10: 375—377.

Fernandez M. , Calvo-Alen J. , Andradi R. et al. The LUMINA cohort as a model for the study of ethnic disparities in systemic lupus eryhematosus. Arthritis Rheum (Arthritis Care & Research), 2007; 57: 576—584.

10.

Gladman DD , Urowitz MB Systemic lupus erythematosus — clinical features. In Hochberg MC , Silman A , Smolen J , Weinblatt M , Weisman M eds. Rheumatology. Mosby, 2007.

11.

Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

12.

Gladman DD , Ibañez D. , Urowitz MB SLE Disease Activity Index 2000. J Rheumatol 2002; 29: 288—291.

13.

Hay EM , Bacon PA , Gordon C. et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447—458.

14.

Gladman DD , Goldsmith CH , Urowitz MB et al. Crosscultural validation of three disease activity indices in SLE: assessment of sensitivity to changes in disease activity. J Rheumatol 1992; 19: 608—611.

15.

Gladman DD , Goldsmith CH , Urowitz MB et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: International validation. J Rheumatol 1994; 21: 1468—1471.

16.

Gladman DD , Ginzler E. , Goldsmith C. et al. Development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 1996; 39: 363—369.

17.

Gladman DD , Urowitz MB , Goldsmith C. et al. The reliability of the SLICC/ACR damage index in patients with SLE. Arthritis Rheum 1997; 40: 809—813.

18.

Rahman P. , Gladman DD , Urowitz MB , Hallett D. , Tam LS Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in SLE. Lupus 2001; 10: 93—96.

19.

Stewart AL , Hayes RD , Ware JE The MOS short-form general health survey: reliability and validity in a patient population. Med Care 1988; 26: 724—735.

20.

Bruce IN , Urowitz MB , Gladman DD , Ibañez D, Steiner G. Risk factors for coronary heart disease (CHD) in women with systemic lupus erythematosus (SLE): The Toronto Risk Factor Study. Arthritis Rheum 2003; 48: 3159—3167.

21.

Fodor JG , Frohlich JJ , Genest Jjg Jr et al. Recommendations for the management of treatment of dyslipidemia. Report of the working group on hypercholesterolemia and other dyslipidemias . CMAJ 2000; 162: 1441—1447.

22.

Kannel WB , Sorlie P. The Framingham study. Arch Int Med 1979; 139: 857—861.

23.

Wilson PW , D'Agostino RB , Levy D. et al. Prediction of coronary hearth disease using risk factor categories . Circulation 1998; 97: 1837—1847.

24.

Bruce IN , Urowitz MB , Gladman DD , Hallet DC The natural history of hypercholesterolaemia in SLE. J Rheumatol 1999; 26: 2137—2143.